My thought on $ADXS
I have been looking for ADXS action lately. Good swings if you have stomach for it.
Near-term target $1.20
Long term
The company has cash into 2022.
A few catalysts
Forthcoming Milestones
*ADXS-503: Phase 1/2 combination with KEYTRUDA--clinical and immune/biomarker data for KEYTRUDA failures as well as first-line patients
ADXS-504: Clinical trial initiation; initial data readout
ADXS-PSA: Announcement of next steps
The first patient dosed with HOT-Prostate by Q1 2021
Near-term target $1.20
Long term
The company has cash into 2022.
A few catalysts
- ADXS-HOT: Off-the-shelf, tumor type-specific constructs
ADXS-503 in NSCLC in Phase 1/2 study
ADXS-504 in prostate cancer scheduled to enter the clinic in Q1 2021
Forthcoming Milestones
*ADXS-503: Phase 1/2 combination with KEYTRUDA--clinical and immune/biomarker data for KEYTRUDA failures as well as first-line patients
ADXS-504: Clinical trial initiation; initial data readout
ADXS-PSA: Announcement of next steps
The first patient dosed with HOT-Prostate by Q1 2021
إخلاء المسؤولية
لا يُقصد بالمعلومات والمنشورات أن تكون، أو تشكل، أي نصيحة مالية أو استثمارية أو تجارية أو أنواع أخرى من النصائح أو التوصيات المقدمة أو المعتمدة من TradingView. اقرأ المزيد في شروط الاستخدام.